Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Atherothrombotic Events”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07440381
What this trial is testing

TriPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE

Who this might be right for
Acute Coronary SyndromesSecondary PreventionLipids
Heart Care Foundation 600
Not applicableStudy completedNCT00761969
What this trial is testing

Prevention of Ischemic Events in Patients With Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
KRKA 1,455
Post-approval studies (Phase 4)Study completedNCT02616497
What this trial is testing

ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)

Who this might be right for
Atherothrombosis
University of Ioannina 1,220
Large-scale testing (Phase 3)Study completedNCT00526474
What this trial is testing

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)

Who this might be right for
AtherosclerosisIschemiaMyocardial Infarction+2 more
Merck Sharp & Dohme LLC 26,449
Not applicableStudy completedNCT04298567
What this trial is testing

Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)

Who this might be right for
Prevention of Atherothrombotic EventsCoronary Artery Disease (CAD)Symptomatic Peripheral Artery Disease (Symptomatic PAD)
Bayer 300
Not applicableStudy completedNCT02673437
What this trial is testing

Rivaroxaban ACS Specialist Cohort Event Monitoring Study

Who this might be right for
Acute Coronary Syndrome
Drug Safety Research Unit, Southampton, UK 701